Free Trial

Climb Bio (CLYM) SEC Filings & 10K Form

Climb Bio logo
$1.34 +0.08 (+6.35%)
As of 04/30/2025 04:00 PM Eastern

Recent Climb Bio SEC Filings

DateFilerForm TypeView
04/01/2025
6:14 AM
Climb Bio, Inc. (Filer)
Climb Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
3:46 PM
Climb Bio, Inc. (Filer)
Climb Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
3:35 PM
Climb Bio, Inc. (Filer)
Climb Bio (Filer)
Form 424B5
03/20/2025
4:21 PM
Climb Bio, Inc. (Issuer)
Climb Bio (Issuer)
Pimblett Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
2:56 PM
BML Investment Partners, L.P. (Filed by)
Climb Bio, Inc. (Subject)
Climb Bio (Subject)
Form SCHEDULE 13G/A
01/15/2025
3:15 PM
Climb Bio, Inc. (Issuer)
Climb Bio (Issuer)
Kaplan Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:15 PM
Climb Bio, Inc. (Issuer)
Climb Bio (Issuer)
Pimblett Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:15 PM
Brennan Aoife (Reporting)
Climb Bio, Inc. (Issuer)
Climb Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:08 AM
Climb Bio, Inc. (Filer)
Climb Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:15 PM
Climb Bio, Inc. (Issuer)
Climb Bio (Issuer)
Pimblett Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2024
11:15 PM
Climb Bio, Inc. (Filer)
Climb Bio (Filer)
Form EFFECT
11/14/2024
8:29 AM
Climb Bio, Inc. (Subject)
Climb Bio (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/12/2024
3:51 PM
Climb Bio, Inc. (Filer)
Climb Bio (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/15/2024
6:08 AM
Climb Bio, Inc. (Filer)
Climb Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
8:53 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Pimblett Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:21 PM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
4:47 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Kaplan Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
4:40 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Kaplan Brett (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/26/2024
6:07 AM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:23 PM
AI ETI LLC (Filed by)
Eliem Therapeutics, Inc. (Subject)
Climb Bio (Subject)
Form SC 13D/A
08/14/2024
5:06 AM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
5:10 AM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2024
11:15 PM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form EFFECT
07/23/2024
4:04 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:31 PM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form 424B3
07/19/2024
10:12 AM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
5:11 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
5:14 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
7:45 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:46 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:42 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:38 PM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form D
Notice of Exempt Offering of Securities 
07/02/2024
3:39 PM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form D
Notice of Exempt Offering of Securities 
07/02/2024
3:01 PM
Deep Track Capital, LP (Filed by)
Eliem Therapeutics, Inc. (Subject)
Climb Bio (Subject)
Form SC 13G
07/01/2024
8:28 PM
Eliem Therapeutics, Inc. (Subject)
Climb Bio (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
07/01/2024
8:29 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
5:09 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Levin Andrew David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
5:14 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:23 PM
Dunn Judith (Reporting)
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:26 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Rosenberg Adam Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:09 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Ratcliffe Liam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
How to invest in Elon Musk’s Optimus before its launch (Ad)

Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that Elon Musk himself believes "will be the biggest product ever of any kind". One well-connected Silicon Valley insider has uncovered a way for anybody to claim a stake in Optimus with as little as $100. All you'll need is a regular brokerage account.

06/28/2024
4:13 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Tate Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Brennan Aoife (Reporting)
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
6:01 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Thomas Stephen Basil (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
6:03 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Thomas Stephen Basil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:05 PM
Brennan Aoife (Reporting)
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:22 PM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
3:23 PM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
1:57 PM
Eliem Therapeutics, Inc. (Issuer)
Climb Bio (Issuer)
Pimblett Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:41 PM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
3:42 PM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form DEFA14A
06/04/2024
7:00 AM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form DEFM14A
06/04/2024
7:05 AM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form ARS
05/15/2024
5:19 AM
Eliem Therapeutics, Inc. (Filer)
Climb Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
5:01 PM
Affinity Asset Advisors, LLC (Filed by)
Eliem Therapeutics, Inc. (Subject)
Climb Bio (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CLYM) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners